EU-Clinical Trials Register - Sindbad
EU-Clinical Trials Register - Sindbad
EU-Clinical Trials Register - Sindbad
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Glossary of Terms used in <strong>EU</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Register</strong><br />
Term<br />
Trial contains a sub-study<br />
Trial has a placebo<br />
Trial is part of a PIP<br />
Trial Phase<br />
Explanation<br />
A sub-study, or ancillary study, is a study performed on a<br />
sub-group of the subjects included in the clinical trial. For<br />
example, a pharmacokinetics or pharmacogenetics substudy<br />
may include a sample of the patients participating in<br />
the clinical trial.<br />
The clinical trial using placebo - A dummy medicine<br />
containing no active ingredients; an inert treatment;<br />
A study is part of a Paediatric Investigation Plan.<br />
The trial phase (Phase I, II, III or IV)<br />
u<br />
US NCT number <strong>Clinical</strong><strong>Trials</strong>.gov registry number. NCT numbers are 8<br />
digits, ascending and correlated with registration date<br />
v<br />
Version (MedDRA)<br />
WHO (UTN)<br />
w<br />
Women of childbearing<br />
potential not using<br />
contraception<br />
Women of child-bearing<br />
potential using contraception<br />
x<br />
The version of MedDRA terminology used<br />
World Health Organisation Universal Trial Number. The UTN<br />
is a number, obtained by the trial's sponsor or principal<br />
investigator and is used for the identification of clinical trials<br />
worldwide<br />
<strong>Clinical</strong> trial includes female subjects who have the potential<br />
to give birth and are not using contraception<br />
<strong>Clinical</strong> trial includes female subjects who have the potential<br />
to give birth and are using contraception<br />
y<br />
z<br />
EMA/534108/2010 Page 12/12